PAIN
Volume 151, Issue 2 , Pages 404-413 , November 2010

Prevention of medication overuse in patients with migraine

  • Günther Fritsche

      Affiliations

    • Department of Neurology and Headache Center, University Hospital Essen, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 201 723 3263; fax: +49 201 723 5939.
    • ,
  • Jule Frettlöh

      Affiliations

    • Department of Pain Management, BG-Klinikum Bergmannsheil, University Hospital Bochum, Germany
    • ,
  • Michael Hüppe

      Affiliations

    • Department of Anaesthesiology, University of Luebeck, Germany
    • ,
  • Martha Dlugaj

      Affiliations

    • Department of Neurology and Headache Center, University Hospital Essen, Germany
    • ,
  • Nadine Matatko

      Affiliations

    • Department of Neurology and Headache Center, University Hospital Essen, Germany
    • ,
  • Charly Gaul

      Affiliations

    • Department of Neurology and Headache Center, University Hospital Essen, Germany
    • Department of Neurology, University Hospital Halle, Germany
    • ,
  • Hans-Christoph Diener

      Affiliations

    • Department of Neurology and Headache Center, University Hospital Essen, Germany
    • ,
  • on Behalf of the Study Group

Received 17 August 2009 ,Revised 14 July 2010 ,Accepted 29 July 2010.

References 

  1. Abt K. Descriptive data analysis: a concept between confirmatory and exploratory data analysis. Methods Inf Med. 1987;26:77–88
  2. Ackermann H. BiAS.für windows. Epsilon, Darmstadt; 2005.
  3. Altieri M, Di Giambattista R, Di Clemente L, Fagiolo D, Tarolla E, Mercurio A, et al. Combined pharmacological and short-term psychodynamic psychotherapy for probable medication overuse headache: a pilot study. Cephalalgia. 2009;29:293–299
  4. Andrasik F. Behavioral treatment approaches to chronic headache. Neurol Sci. 2003;24:80–85
  5. Basler HD, Jäkle C, Kröner-Herwig B. Cognitive-behavioral therapy for chronic headache at German pain centers. Int J Rehab Health. 1996;2:235–252
  6. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the hospital anxiety and depression scale: an updated literature review. J of Psychosom Res. 2002;25:69–77
  7. Blanchard EB. Psychological treatment of benign headache disorders. J Consult Clin Psychol. 1992;60:537–551
  8. Campbell JK, Penzien DB, Wall EM. Evidence-based guidelines for migraine headaches: behavioral and psychological treatments, <www.aan.com/public>; 2004.
  9. Denecke H, Glier B, Klinger R, Nilges P, Redegeld M, Weiß L, et al. Quality assurance in therapy of chronic pain. Results obtained by a taskforce of the German Section of the Association for the Study of Pain on psychological assessment of chronic pain. Schmerz. 1995;9:39–42
  10. Diener HC, Küper M, Kurth T. Migraine-associated risks and comorbidity. J Neurol. 2008;255:1290–1301
  11. Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, et al. EFNS guideline on the drug treatment of migraine – report of an EFNS task force. Eur J Neurol. 2006;13:560–572
  12. Flor H, Behle DJ, Birbaumer N. Assessment of pain-related cognitions in chronic pain patients. Behav Res Ther. 1993;31:63–73
  13. Flor H. Psychobiologie des Schmerzes. Bern: Huber; 1991.
  14. Fritsche G, Hueppe M, Kukava M, Dzagnidze A, Schuerks M, Yoon MS, et al. Validation of a german language questionnaire for screening for migraine, tension-type headache, and trigeminal autonomic cephalgias. Headache. 2007;47:546–551
  15. Fritsche G, Nitsch C, Pietrowski R, Diener HC. Psychological descriptors of excessive use of analgesic medication. Schmerz. 2000;14:217–225
  16. Grazzi L, Andrasik F, D’Amico D, Leone M, Usai S, Kass SJ, et al. Behavioral and pharmacologic treatment of transformed migraine with analgesic overuse: outcome at 3 years. Headache. 2002;42:483–490
  17. Herrmann-Lingen C, Buss U, Snaith RP. Hospital anxiety and depression scale – Deutsche Version. Göttingen: Hogrefe; 1995.
  18. Holroyd KA, Drew JB. Behavioral approaches to the treatment of migraine. Semin Neurol. 2006;26:199–207
  19. ICHD-2: Headache Classification Committee of the International Headache Society. The international classification of headache disorders [2nd ed.]. Cephalalgia 2004;24(Suppl. 1):1–160.
  20. Katsarava Z, Schneeweiss S, Kurth T, Kroener U, Fritsche G, Eikermann A, et al. Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology. 2004;62:788–790
  21. Lohaus A, Schmitt GM. Kontrollüberzeugungen zu Krankheit und Gesundheit (KKG). Göttingen: Hogrefe; 1989.
  22. Lohaus A, Schmitt GM. Kontrollüberzeugungen zu Krankheit und Gesundheit (KKG): Bericht über die Entwicklung eines Testverfahrens. Diagnostica; 1989.
  23. Lu SR, Fuh JL, Chen WT, Juang KD, Wang SJ. Chronic daily headache in Taipei, Taiwan: prevalence, follow-up and outcome predictors. Cephalalgia. 2001;21:980–986
  24. Marrs RW. A meta-analysis of bibliotherapy studies. Am J Community Psychol. 1995;23:843–870
  25. Mathew NT, Kurman R, Perez F. Drug induced refractory headache – clinical features and management. Headache. 1990;30:634–638
  26. Mathew NT. Transformed migraine. Cephalalgia. 1993;78–83
  27. McCracken LM, Vowles KE, Eccleston C. Acceptance of chronic pain: component analysis and a revised assessment method. Pain. 2004;107:159–166
  28. McCracken LM. Learning to live with the pain: acceptance of pain predicts adjustment in persons with chronic pain. Pain. 1998;74:21–27
  29. Meichenbaum DH. In: Cognitive behavior modificafion. Morristown NJ: General Learning Press; 1974.
  30. Nicholson RA, Houle TT, Rhudy JL, Norton PJ. Psychological risk factors in headache. Headache. 2007;47:413–426
  31. Nilges P, Köster B, Schmidt CO. Pain acceptance – concept and validation of a German version of the chronic pain acceptance questionnaire. Schmerz. 2007;21:60–67
  32. Radat F, Creach C, Swendsen JD, Lafittau M, Irachabal S, Dousset V, et al. Psychiatric comorbidity in the evolution from migraine to medication overuse headache. Cephalalgia. 2005;25:519–522
  33. Redillas C, Solomon S. Prophylactic pharmacologic treatment of chronic daily headache. Headache. 2000;40:83–102
  34. Rosenstiel AK, Keefe FJ. The use of coping strategies in chronic low-back pain patients: Relationship to patient characteristics and current adjustment. Pain. 1983;17:33–44
  35. Rotter JB. Generalized expectancies for internal versus external control of reinforcement. Psychol Monogr. 1966;80:1–28
  36. Saper JR, Silberstein SD, Lake AE, Winters ME. Double-blind trial of fluoxetine: chronic daily headache and migraine. Headache. 1994;34:497–502
  37. Scher AI, Lipton RB, Stewart W. Risk factors for chronic daily headache. Curr Pain Headache Rep. 2002;6:486–491
  38. Turk DC, Dworkin RH, Allen RR, Bellamy N, Brandenburg N, Carr DB, et al. Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain. 2003;106:337–345
  39. Turk DC, Dworkin RH, McDermott MP, Bellamy N, Burke LB, Chandler JM, et al. Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations. Initiative on methods, measurement, and pain assessment in clinical trials. Pain. 2008;139:485–493
  40. Turk DC, Rudy TE. Assessment of cognitive factors in chronic pain: a worthwhile enterprise?. J Consult Clin Psychiat. 1986;54:760–768
  41. Wallston KA, Wallston BS, DeVellis R. Development of the multidimensional health locus of control (MHLC) scales. Health Educ Monogr. 1978;6:160–170
  42. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiat Scand. 1983;67:361–370
  43. Zwart JA, Dyb G, Hagen K, Svebak S, Holmen J. Analgesic use: a predictor of chronic pain and medication overuse headache: the Head-HUNT Study. Neurology. 2003;22:160–164

PII: S0304-3959(10)00466-5

doi: 10.1016/j.pain.2010.07.032

PAIN
Volume 151, Issue 2 , Pages 404-413 , November 2010

Article Tools

* Image Usage & Resolution